Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025 Bicycle Toxin Conjugates Are Emerging As New Novel Class Of Drugs For Cancer Says Kuick Research GlobeNewswire August 29, 2025 Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) — Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms & Market Opportunity Insight 2025 Report Highlights: […]

RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025 RNA Polymerase I Are emerging As ne treatment Methodology In Oncology Domain Says Kuick Research GlobeNewswire August 29, 2025 Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) — Global RNA Polymerase I Clinical Trials, Development Trends By Indications, Target Approaches & Market Opportunity

STRONG SALES GROWTH AND INCREASED EARNINGS IN THE SECOND QUARTER Revenue for the second quarter of 2025 amounted to SEK 794.4 million (507.0), representing growth of 57% (24%) compared with the same period last year. In local currencies, revenue increased by 62% year over year. EBITDA rose to SEK 79.7 million (63.0), with an EBITDA

“Hong Kong, our advantage is you and theICAC”. For nearly two decades, the slogan of the Independent Commission Against Corruption (ICAC), the city's dedicated anti-graft agency, has been deeply rooted in people's heart. Established in 1974 in response to public demand, theICAC fights corruption in Hong Kong with a holistic strategy comprising law enforcement, corruption

STOCKHOLM, SE / ACCESS Newswire / August 29, 2025 / Hilbert Group (STO:HILB-B) (FRA:999) August 29, 2025The second quarter 2025(compared to second quarter 2024) Revenues amounted to KSEK 46,224.2 (KSEK 27,304.1) Operating profit/loss (EBIT) totalled KSEK -18,068.2 (KSEK -13,736.7) Results for the period were KSEK -26,270.8 (KSEK -14,996.8) Net Cash flow from operating activities amounted

“Hong Kong, our advantage is you and theICAC”. For nearly two decades, the slogan of the Independent Commission Against Corruption (ICAC), the city's dedicated anti-graft agency, has been deeply rooted in people's heart. Established in 1974 in response to public demand, theICAC fights corruption in Hong Kong with a holistic strategy comprising law enforcement, corruption

Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025 First Tetraspecific Antibodies Commercial Launch Expected By 2029 Says Kuick Research GlobeNewswire August 29, 2025 Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) — Global Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches & Market Opportunity Insight 2025 Report Finding & Highlights: First

Noah Holdings Limited (“Noah” or the “Company”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for global Chinese high-net-worth investors (“HNWIs”), reported unaudited financial results for three months and six months ended June 30, 2025. Net revenues for the

Hitachi Energy, a global leader in electrification, has completed the acquisition of the remaining stake in eks Energy, a technology and market leader in power electronics and control solutions to deliver a scalable, flexible, and complete approach for energy storage customers. Hitachi Energy acquired a majority stake in eks Energy in 2023. As energy storage

CoinShares International Limited (“CoinShares'' or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European asset manager specialising in digital assets, has today published its results for the quarter ending 30th June 2025. https://mma.prnewswire.com/media/2339126/CoinShares_Logo.jpg Q2 2025 Financial Highlights — Asset Management fees of $30.0 million (Q2 2024: $28.3 million) — Capital Markets gains/income of